Salivary Gland Cancer Clinical Trials

• Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00004163 - Active, not recruiting
  salivary gland malignant mixed cell type tumor; salivary gland poorly differentiated carcinoma; stage III salivary gland cancer; ...
  
• Trastuzumab in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00126607 - Active, not recruiting
  recurrent salivary gland cancer; high-grade salivary gland mucoepidermoid carcinoma; salivary gland acinic cell tumor; stage IV salivary gland cancer; ...
  
• Imatinib Mesylate in Treating Patients With Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00045669 - Active, not recruiting
  recurrent salivary gland cancer; salivary gland adenoid cystic carcinoma; stage III salivary gland cancer; stage IV salivary gland cancer
  
• Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers
  ClinicalTrials.gov Identifier: NCT00095563 - Active, not recruiting
  high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer
  
• Capecitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Salivary Gland Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00101075 - Active, not recruiting
  high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer
  
• Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003744 - Active, not recruiting
  high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer
  
• Cisplatin or Carboplatin Combined With Gemcitabine in Treating Patients With Locally Advanced, Recurrent, or Metastatic Malignant Salivary Gland Tumor
  ClinicalTrials.gov Identifier: NCT00079079 - Recruiting
  high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer
  
• Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00017498 - Active, not recruiting
  stage IV salivary gland cancer; recurrent salivary gland cancer; salivary gland adenoid cystic carcinoma; ...
  
• Paclitaxel in Treating Patients With Metastatic or Recurrent Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00002632 - Completed
  stage IV salivary gland cancer; recurrent salivary gland cancer; high-grade salivary gland mucoepidermoid carcinoma; salivary gland adenocarcinoma
  
• Iressa Study in Patients With Salivary Gland Cancer
  ClinicalTrials.gov Identifier: NCT00509002 - Active, not recruiting
  Salivary Gland Cancer
  
• Biological Therapy in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00004604 - Active, not recruiting
  Lung Cancer; Testicular Cancer; ovarian epithelial cancer; Pancreatic Cancer; Colon Cancer; Thyroid Cancer; Gastric Cancer; Salivary Gland Cancer; ...
  
• Gene Therapy in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
  
• Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003251 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Cisplatin Plus Gemcitabine in Treating Patients With Advanced Squamous Cell Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003264 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Salivary Evaluation in Normal Volunteers
  ClinicalTrials.gov Identifier: NCT00001390 - Recruiting
  Healthy; Salivary Gland Disease
  
• Cisplatin and Gemcitabine in Treating Patients With Advanced Squamous Cell Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00003182 - Active, not recruiting
  Salivary Gland Cancer; Oral Cancer; Lip Cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022373 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Paclitaxel and Cisplatin Plus Radiation Therapy Followed by Filgrastim in Treating Patients With Recurrent Head and Neck Cancer or Lung Cancer
  ClinicalTrials.gov Identifier: NCT00021333 - Active, not recruiting
  Lung Cancer; Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Thyroid Cancer; Oropharyngeal Cancer
  
• Natural History of Salivary Gland Dysfunction and Sjogren's Syndrome
  ClinicalTrials.gov Identifier: NCT00001852 - Recruiting
  Lymphoma; Salivary Gland Disease; Sjogren's Syndrome; Xerostomia
  
• EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00004261 - Active, not recruiting
  Salivary Gland Cancer; lip and oral cavity cancer; adult soft tissue sarcoma; Head and Neck Cancer; Prostate Cancer; Cervical Cancer; ...
  
• Celecoxib and/or EKB-569 in Preventing Oral Cancer in Patients With Oral Leukoplakia
  ClinicalTrials.gov Identifier: NCT00088842 - Not yet recruiting
  lip and oral cavity cancer; Salivary Gland Cancer; Precancerous Condition
  
• Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003856 - Active, not recruiting
  recurrent squamous cell carcinoma of the oropharynx; recurrent squamous cell carcinoma of the hypopharynx; recurrent salivary gland cancer; ...
  
• Bortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma (Cancer) of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00077428 - Completed
  lip and oral cavity cancer; Salivary Gland Cancer
  
• Capsaicin Lozenges in Treating Patients With Mucositis Caused by Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00003610 - Completed
  Salivary Gland Cancer; lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Methotrexate Compared With Paclitaxel in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003592 - Active, not recruiting
  stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity; stage IV squamous cell carcinoma of the lip and oral cavity; ...
  
• A Pilot Study to Evaluate the Feasibility of Combining Submandibular Salivary Gland Tx & IMRT Tomo to Reduce Xerostomia
  ClinicalTrials.gov Identifier: NCT00497406 - Recruiting
  Head and Neck Cancer
  
• RK-0202 in Preventing Oral Mucositis in Patients Who are Undergoing Radiation Therapy for Cancer of the Mouth, Throat, or Salivary Glands
  ClinicalTrials.gov Identifier: NCT00046956 - Recruiting
  lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; Oropharyngeal Cancer; radiation toxicity; ...
  
• Trial Comparing Oral Pilocarpine (Salagen) Versus Submandibular Salivary Gland Transfer Protocol, For the Prevention of Radiation (XRT) Induced Xerostomia in Head and Neck Cancer Patients
  ClinicalTrials.gov Identifier: NCT00168181 - Recruiting
  Cancer; Head and Neck Cancer
  
• SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00095628 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Adjuvant Chemoradiotherapy Using Cisplatin and Docetaxel After Complete Resection in Treating Patients With Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00084435 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00372320 - Recruiting
  Parotid Salivary Dysfunction
  
• Salivary Gland Surgery Before Radiation Therapy in Preventing Radiation-Caused Xerostomia in Patients With Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00068237 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; metastatic squamous neck cancer with occult primary; ...
  
• Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00089297 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• DHEA Treatment for Sjogren's Syndrome
  ClinicalTrials.gov Identifier: NCT00001598 - Completed
  Lacrimal Apparatus Disease; Salivary Gland Disease; Sjogren's Syndrome; Xerostomia
  
• Phase I of Biologics and Chemoradiation Therapy for Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00405405 - Recruiting
  Head and Neck Cancer.; Parotid Gland, Thyroid Gland and Melanoma Cases; Stage IV Head and Neck Caner
  
• Evaluation of Salivary Gland Dysfunction
  ClinicalTrials.gov Identifier: NCT00001196 - Recruiting
  Sjogren's Syndrome; Xerostomia
  
• Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00167908 - Active, not recruiting
  Head and Neck Cancer
  
• Study of Adrenal Gland Tumors
  ClinicalTrials.gov Identifier: NCT00005927 - Recruiting
  Adrenal Gland Neoplasm
  
• BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00057850 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
  
• Amifostine With IMRT for Submandibular and Sublingual Salivary Sparing During Head and Neck Cancer Treatment
  ClinicalTrials.gov Identifier: NCT00409331 - Recruiting
  Head and Neck Cancer
  
• Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00017511 - Completed
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; metastatic squamous neck cancer with occult primary; Nasopharyngeal Cancer; ...
  
• Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002602 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate
  
• Potential of Transplanted Stem Cells to Mature into Salivary Gland and Cheek Cells
  ClinicalTrials.gov Identifier: NCT00023491 - Completed
  Graft vs Host Disease; Sjogren's Syndrome
  
• Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients with Adrenal Insufficiency
  ClinicalTrials.gov Identifier: NCT00001180 - Completed
  Adrenal Gland Hyperfunction; Adrenal Gland Hypofunction; Cushing's Syndrome; Healthy
  
• A Phase I/II Feasibilty/Efficacy Study Using Intensity-Modulated Radiation Therapy in Head and Neck (H&N) Cancer Patients to Permit Sparing of Parotid Gland Function.
  ClinicalTrials.gov Identifier: NCT00137475 - Recruiting
  -head and neck cancer
  
• Iodine I-131 Iodocholesterol, its use in adrenal screening
  ClinicalTrials.gov Identifier: NCT00037843 - Completed
  Adrenal Gland Diseases; Adrenal Gland Neoplasms
  
• Salivary Catecholamines in Aphthous Stomatitis (Canker Sores)
  ClinicalTrials.gov Identifier: NCT00556686 - Recruiting
  Canker Sore
  
• Safety and Efficacy Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients with ALS
  ClinicalTrials.gov Identifier: NCT00125203 - Active, not recruiting
  Amyotrophic Lateral Sclerosis; Sialorrhea
  
• Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
  ClinicalTrials.gov Identifier: NCT00003453 - Recruiting
  stage IV adrenocortical carcinoma; recurrent adrenocortical carcinoma
  
• Diagnostic Accuracy of Fine Needle Aspiration in Parotid Tumors
  ClinicalTrials.gov Identifier: NCT00534612 - Recruiting
  Parotid Gland Neoplasms
  
• Zinc Supplements in Lowering Cadmium Levels in Smokers
  ClinicalTrials.gov Identifier: NCT00376987 - Active, not recruiting
  Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
  
• Prevalence of Salivary Hypofunction in Patients With Globus Pharyngeus
  ClinicalTrials.gov Identifier: NCT00381771 - Recruiting
  Globus Pharyngeus
  
• Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer
  ClinicalTrials.gov Identifier: NCT00287885 - Active, not recruiting
  Cervical Cancer; Endometrial Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer; Sarcoma; Vaginal Cancer; Vulvar Cancer
  
• A Phase I Study of ECO-4601 in Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00338026 - Active, not recruiting
  Tumors; Glioma; Colorectal Cancer; Lung Cancer; Breast Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer
  
• Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
  ClinicalTrials.gov Identifier: NCT00433602 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Thromboembolism
  
• Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
  ClinicalTrials.gov Identifier: NCT00003170 - Active, not recruiting
  Pancreatic Cancer; Vulvar Cancer; Renal Cell Cancer; Endometrial Cancer; Testicular Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer; ...
  
• Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
  ClinicalTrials.gov Identifier: NCT00019513 - Active, not recruiting
  Colorectal Cancer; Esophageal Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Liver Cancer; Lung Cancer; Lymphoma; Pancreatic Cancer; Small Intestine Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients
  ClinicalTrials.gov Identifier: NCT00268918 - Active, not recruiting
  Ovarian Cancer; Endometrial Cancer; Cervical Cancer; Fallopian Tube Cancer; Peritoneal Cancer; Breast Cancer
  
• Phase I Study of SU006668 in Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00024063 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Renal Cell Cancer; Colorectal Cancer; Colon Cancer; Prostate Cancer; Rectal Cancer; Breast Cancer; ...
  
• Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00544193 - Active, not recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Pancreatic Cancer; Small Intestine Cancer
  
• Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia
  ClinicalTrials.gov Identifier: NCT00056004 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Lung Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer
  
• Testosterone Gel Applied to Women with Pituitary Gland Problems
  ClinicalTrials.gov Identifier: NCT00144391 - Recruiting
  Panhypopituitarism
  
• Correlation Salivary Cortisol and Free Serum Cortisol to Total Serum Cortisol in MICU Septic Shock
  ClinicalTrials.gov Identifier: NCT00523198 - Recruiting
  Septic Shock
  
• Irinotecan and Capecitabine in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003867 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer; Colon Cancer; Rectal Cancer; Breast Cancer
  
• Spectroscopy With Surface Coils and Decoupling
  ClinicalTrials.gov Identifier: NCT00581815 - Recruiting
  Adrenal Cortical Cancer; Brain Cancer; Breast Cancer; CNS Cancer; Colon Cancer; HEENT Cancer; Hodgkin's Disease; Kaposi's Sarcoma; Liver Cancer; Lung Cancer; Non-Hodgkin's Lymphoma; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer; Rectal Cancer; Renal Cancer; Sarcoma; Squamous Cell Carcinoma; Thyroid Cancer
  
• High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00002854 - Active, not recruiting
  Breast Cancer; Gastrointestinal Cancer; Kidney Cancer; Musculoskeletal Cancer; Reproductive Cancer; Skin Cancer
  
• Oral Mucositis in Patients Receiving Radiation Therapy for Cancer of the Mouth, Pharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004234 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; oral complications of cancer and cancer therapy; ...
  
• Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00005049 - Active, not recruiting
  female reproductive cancer; Gastrointestinal Cancer; unclassified and other cancer
  
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00003427 - Active, not recruiting
  Pancreatic Cancer; Colon Cancer; Gastric Cancer; Rectal Cancer; Esophageal Cancer; Colorectal Cancer; adult primary liver cancer
  
• Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium and Decreased Kidney Function
  ClinicalTrials.gov Identifier: NCT00005644 - Active, not recruiting
  Bladder Cancer; Cancer of the Renal Pelvis and Ureter; Gastrointestinal Cancer; Urethral Cancer
  
• Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients with High Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00108290 - Completed
  Prostate Cancer
  
• Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer
  ClinicalTrials.gov Identifier: NCT00002520 - Active, not recruiting
  Leukemia; Lymphoma; Head and Neck Cancer; Lung Cancer; Eye Cancer; Gastrointestinal Cancer; Oral Cancer; Reproductive Cancer
  
• Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity
  ClinicalTrials.gov Identifier: NCT00003548 - Active, not recruiting
  Gastrointestinal Cancer; Pancreatic Cancer; Liver Cancer; Female Reproductive Cancer
  
• Genetic Study of Patients and Families With a History of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003648 - Active, not recruiting
  Colon Cancer; Gastrointestinal Cancer; Rectal Cancer
  
• A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women
  ClinicalTrials.gov Identifier: NCT00376909 - Active, not recruiting
  Breast Cancer; Cervical Cancer; Colorectal Cancer
  
• Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction
  ClinicalTrials.gov Identifier: NCT00004910 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; Colon Cancer
  
• Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
  ClinicalTrials.gov Identifier: NCT00026468 - Active, not recruiting
  Colon Cancer; Rectal Cancer; small intestine cancer
  
• Diet and PSA Levels in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003367 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; stage I prostate cancer; adenocarcinoma of the prostate; ...
  
• Conventional Care With or Without Specialized Cancer Care in Treating Patients Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00006253 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Endometrial Cancer; Colorectal Cancer; ovarian epithelial cancer; Lymphoma; Colon Cancer; Breast Cancer
  
• Liposomal Lurtotecan in Treating Patients With Metastatic or Locally Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00022594 - Active, not recruiting
  Neck Cancer; Oral Cancer; Throat Cancer
  
• Celecoxib to Prevent Colorectal Cancer in Patients Who Have Undergone Surgery to Remove Polyps
  ClinicalTrials.gov Identifier: NCT00005094 - Active, not recruiting
  prevention of colorectal cancer; Colon Cancer; Rectal Cancer
  
• Capecitabine Combined with Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00010023 - Active, not recruiting
  Breast Cancer; Gastrointestinal Cancer; Head and Neck Cancer; thorax and respiratory cancer; unclassified and other cancer
  
• Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer
  ClinicalTrials.gov Identifier: NCT00165464 - Active, not recruiting
  Esophageal Cancer; Gastric Cancer; GE Junction Cancer
  
• Topotecan in Combination With Pemetrexed in Patients With Advanced Malignancies
  ClinicalTrials.gov Identifier: NCT00315861 - Active, not recruiting
  Ovarian Cancer; Endometrial Cancer; Cervical Cancer; Lung Cancer
  
• Bupropion in Helping Adults Stop Smoking
  ClinicalTrials.gov Identifier: NCT00534001 - Recruiting
  Bladder Cancer; Cervical Cancer; Esophageal Cancer; Gastric Cancer; Head and Neck Cancer; Kidney Cancer; Leukemia; Liver Cancer; Lung Cancer; Pancreatic Cancer; Tobacco Use Disorder
  
• Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00049608 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; Lung Cancer; Pancreatic Cancer
  
• Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
  ClinicalTrials.gov Identifier: NCT00342992 - Active, not recruiting
  Lung Cancer; Prostatic Neoplasms; Prostate Cancer; Pancreatic Cancer
  
• Eflornithine Plus Sulindac in Preventing Colorectal Cancer in Patients Who Have Had Surgery to Remove Benign Colorectal Polyps
  ClinicalTrials.gov Identifier: NCT00005882 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Folate-Depleted Diet Compared With Folate-Supplemented Diet in Preventing Colorectal Cancer in Patients at High Risk for Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00096330 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Interleukin-12 in Treating Patients With Cancer in the Abdomen
  ClinicalTrials.gov Identifier: NCT00003046 - Active, not recruiting
  Pancreatic Cancer; Gastric Cancer; Colorectal Cancer; Colon Cancer; Rectal Cancer
  
• Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
  ClinicalTrials.gov Identifier: NCT00095836 - Active, not recruiting
  anaplastic thyroid cancer; follicular thyroid cancer; medullary thyroid cancer; papillary thyroid cancer; Thyroid Cancer
  
• Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00006026 - Active, not recruiting
  Bladder Cancer; Kidney Cancer; Urethral Cancer
  
• Chemotherapy Administered Every 2 Weeks with or without Pegfilgrastim (Neulasta) in Subjects with Advanced Colon Cancer
  ClinicalTrials.gov Identifier: NCT00094809 - Active, not recruiting
  Colon Cancer; Colorectal Cancer; Rectal Cancer
  
• Collection of Specimens to be Used for Studying the Causes, Diagnosis, Prevention, and Treatment of Cancer
  ClinicalTrials.gov Identifier: NCT00580554 - Recruiting
  Appendiceal Cancer; Cervical Cancer; Endometrial Cancer; Fallopian Tube Disease; Gestational Trophoblastic Neoplasms; Ovarian Cancer; Peritoneal Cancer; Uterine Cancer; Vaginal Cancer; Vulvar Cancer
  
• Chemotherapy in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003103 - Active, not recruiting
  Gastrointestinal Cancer; Head and Neck Cancer; Kidney Cancer; Lung Cancer; Oral Cancer; Reproductive Cancers
  
• Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004095 - Active, not recruiting
  Bladder Cancer; Breast Cancer; Colorectal Cancer; kidney tumor; Lung Cancer; Pancreatic Cancer
  
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients with Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00006051 - Active, not recruiting
  Throat Cancer; Oral Cancer
  
• Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction
  ClinicalTrials.gov Identifier: NCT00004911 - Active, not recruiting
  Gastric Cancer; Colorectal Cancer; Colon Cancer; Rectal Cancer
  
• Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00080873 - Active, not recruiting
  Cancer; oral complications of cancer and cancer therapy
  
• Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy
  ClinicalTrials.gov Identifier: NCT00004865 - Active, not recruiting
  Nose Cancer; Oral Cancer; Throat Cancer